These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 10711765

  • 21. Effects of buflomedil on microvascular disorders in diabetic patients.
    Le Dévéhat C, Vimeux M, Bondoux G, Khodabandehlou T.
    Blood Vessels; 1991; 28 Suppl 1():38-43. PubMed ID: 1932765
    [Abstract] [Full Text] [Related]

  • 22. Hyperbaric oxygen, oxidative stress, NO bioavailability and ulcer oxygenation in diabetic patients.
    Efrati S, Gall N, Bergan J, Fishlev G, Bass A, Berman S, Hamad-Abu R, Feigenzon M, Weissgarten J.
    Undersea Hyperb Med; 2009; 36(1):1-12. PubMed ID: 19341122
    [Abstract] [Full Text] [Related]

  • 23. Altered postural regulation of foot skin oxygenation and blood flow in patients with type 2 diabetes mellitus.
    Iwase M, Imoto H, Murata A, Nakamura U, Nohara S, Uchizono Y, Iino K, Iida M.
    Exp Clin Endocrinol Diabetes; 2007 Jul; 115(7):444-7. PubMed ID: 17647142
    [Abstract] [Full Text] [Related]

  • 24. Buflomedil and pentoxifylline in the viability of dorsal cutaneous flaps of rats treated with nicotine.
    Mauad RJ, Shimizu MH, Mauad T, de Tolosa EM.
    J Plast Reconstr Aesthet Surg; 2006 Jul; 59(4):387-92. PubMed ID: 16756255
    [Abstract] [Full Text] [Related]

  • 25. [Protective effect of buflomedil hydrochloride on erythrocyte sickling. In vitro study].
    Briguglio F, Briguglio E, Di Marco V.
    Minerva Med; 1986 Feb 28; 77(7-8):249-62. PubMed ID: 3951731
    [Abstract] [Full Text] [Related]

  • 26. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
    Limbs International Medicinal Buflomedil (LIMB) Study Group, Leizorovicz A, Becker F.
    Circulation; 2008 Feb 12; 117(6):816-22. PubMed ID: 18212283
    [Abstract] [Full Text] [Related]

  • 27. Buflomedil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in peripheral and cerebral vascular diseases.
    Clissold SP, Lynch S, Sorkin EM.
    Drugs; 1987 May 12; 33(5):430-60. PubMed ID: 3297620
    [Abstract] [Full Text] [Related]

  • 28. [Validity of the transcutaneous PO2-measurement during pharmacologically induced changes of skin perfusion (author's transl)].
    Wendling P, Füssinger R, Schmidt HD, Stosseck K.
    Anaesthesist; 1982 Mar 12; 31(3):135-8. PubMed ID: 7072928
    [Abstract] [Full Text] [Related]

  • 29. Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus.
    Szerafin T, Erdei N, Fülöp T, Pasztor ET, Edes I, Koller A, Bagi Z.
    Circ Res; 2006 Sep 01; 99(5):e12-7. PubMed ID: 16917094
    [Abstract] [Full Text] [Related]

  • 30. Sympathetic autoregulation in peripheral vascular disease.
    Delis KT, Lennox AF, Nicolaides AN, Wolfe JH.
    Br J Surg; 2001 Apr 01; 88(4):523-8. PubMed ID: 11298619
    [Abstract] [Full Text] [Related]

  • 31. Effects of buflomedil and its two derivatives, CRL40634 and CRL40598, on pancreatic exocrine secretion in the rat.
    Chariot J, Nagain C, Vaille C, Rozé C.
    Eur J Pharmacol; 1990 Jan 17; 175(3):229-35. PubMed ID: 2323347
    [Abstract] [Full Text] [Related]

  • 32. [Clinical study of the effect of buflomedil on peripheral neuropathy in diabetic patients].
    Zhou M, Lei MX.
    Hunan Yi Ke Da Xue Xue Bao; 2001 Jun 28; 26(3):239-40. PubMed ID: 12536693
    [Abstract] [Full Text] [Related]

  • 33. [Decrease of blood viscosity induced by buflomedil in healthy volunteers].
    Craveri A, Tornaghi G, Paganardi L, Ranieri R, Di Bella M.
    Minerva Cardioangiol; 1988 Jun 28; 36(7-8):357-60. PubMed ID: 3211334
    [No Abstract] [Full Text] [Related]

  • 34. Measurement of the cutaneous blood flow reserve in normal humans by laser-Doppler flowmetry.
    Vayssairat M, Chabbert-Buffet N, Gaitz JP, Tribout L, Abdoucheli-Baudot N.
    Int Angiol; 2004 Sep 28; 23(3):255-8. PubMed ID: 15765040
    [Abstract] [Full Text] [Related]

  • 35. [Effectiveness of buflomedil in arterial occlusive disease. Modification of transcutaneous oxygen pressure in a placebo-controlled double-blind study].
    Sunder-Plassmann L, Gandolfo AM, Utz C.
    MMW Munch Med Wochenschr; 1984 Mar 02; 126(9):247-8. PubMed ID: 6425678
    [No Abstract] [Full Text] [Related]

  • 36. In defense of microvascular constriction in diabetes.
    Wiernsperger NF.
    Clin Hemorheol Microcirc; 2001 Mar 02; 25(2):55-62. PubMed ID: 11790871
    [Abstract] [Full Text] [Related]

  • 37. The influence of exercise on foot perfusion in diabetes.
    Williams DT, Harding KG, Price PE.
    Diabet Med; 2007 Oct 02; 24(10):1105-11. PubMed ID: 17593240
    [Abstract] [Full Text] [Related]

  • 38. An experimental overview of a new vasoactive drug: buflomedil HCl.
    Dubourg A, Scamuffa RF.
    Angiology; 1981 Oct 02; 32(10):663-75. PubMed ID: 7034590
    [Abstract] [Full Text] [Related]

  • 39. S-nitrosoglutathione-containing hydrogel increases dermal blood flow in streptozotocin-induced diabetic rats.
    Seabra AB, Pankotai E, Fehér M, Somlai A, Kiss L, Bíró L, Szabó C, Kollai M, de Oliveira MG, Lacza Z.
    Br J Dermatol; 2007 May 02; 156(5):814-8. PubMed ID: 17263816
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of bronchial hyperresponsiveness by monitoring of transcutaneous oxygen tension and arterial oxygen saturation during methacholine challenge in asthmatic children.
    Wang J, Mochizuki H, Muramatsu R, Arakawa H, Tokuyama K, Morikawa A.
    J Asthma; 2006 Mar 02; 43(2):145-9. PubMed ID: 16517431
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.